Who owns Engene Therapeutics Inc?
- Ticker: ENGN
- CUSIP Number: 29286x101
Tip: Access positions for across all investors
Analyze quarterly positions in Engene Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Engene Therapeutics stock
Who bought or sold Engene Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BML Capital Management | 6.7M | $12M | 100% | Jun 2026 |
|
| Siren | 6.3M | $11M | 100% | Jun 2026 |
|
| Perceptive Advisors | 4.8M | $8.3M | 100% | Jun 2026 |
|
| Ameriprise Financial | 2.7M | $4.6M | 100% | Jun 2026 |
|
| Nextech Invest | 2.3M | $4.0M | 100% | Jun 2026 |
|
| ADAR1 Capital Management | 2.1M | $3.6M | 100% | Jun 2026 |
|
| Vestal Point Capital | 1.7M | $2.9M | 100% | Jun 2026 |
|
| Acorn Capital Advisors | 1.3M | $2.2M | 100% | Jun 2026 |
|
| Peapod Lane Capital | 1.1M | $1.9M | 100% | Jun 2026 |
|
| Balyasny Asset Management | 1.0M | $1.7M | 100% | Jun 2026 |
|
| Millennium Management | 967k | $1.7M | 100% | Jun 2026 |
|
| Renaissance Technologies | 830k | $1.4M | 100% | Jun 2026 |
|
| Citadel Advisors | 781k | $1.4M | 100% | Jun 2026 |
|
| Affinity Asset Advisors | 600k | $1.0M | 100% | Jun 2026 |
|
| UBS Group | 509k | $881k | 100% | Jun 2026 |
|
| Eversept Partners | 470k | $812k | 100% | Jun 2026 |
|
| Kynam Capital Management | 458k | $792k | 100% | Jun 2026 |
|
| Jane Street | 456k | $789k | 100% | Jun 2026 |
|
| Seven Fleet Capital Management | 411k | $711k | 100% | Jun 2026 |
|
| Susquehanna International | 400k | $691k | 100% | Jun 2026 |
|
| Rangeley Capital | 305k | $528k | 100% | Jun 2026 |
|
| Barclays | 283k | $489k | 100% | Jun 2026 |
|
| Kennedy Capital Management | 269k | $465k | 100% | Jun 2026 |
|
| Woodline Partners | 250k | $433k | 100% | Jun 2026 |
|
| Quadrature Capital | 239k | $414k | 100% | Jun 2026 |
|
| Squarepoint Ops | 215k | $373k | 100% | Jun 2026 |
|
| Elmind Capital | 210k | $363k | 100% | Jun 2026 |
|
| Qube Research & Technologies | 200k | $346k | 100% | Jun 2026 |
|
| Privium Fund Management B.V. | 170k | $294k | 100% | Jun 2026 |
|
| Two Sigma Investments | 165k | $285k | 100% | Jun 2026 |
|
| XTX Topco | 151k | $262k | 100% | Jun 2026 |
|
| Marquette Asset Management | 151k | $260k | 100% | Jun 2026 |
|
| Persistent Asset Partners | 115k | $198k | 100% | Jun 2026 |
|
| DAFNA Capital Management | 75k | $129k | 100% | Jun 2026 |
|
| Jain Global | 43k | $75k | 100% | Jun 2026 |
|
| Scientech Research | 41k | $70k | 100% | Jun 2026 |
|
| Verdad Advisers | 39k | $68k | 100% | Jun 2026 |
|
| Dimensional Fund Advisors | 38k | $66k | 100% | Jun 2026 |
|
| GSA Capital Partners | 37k | $65k | 100% | Jun 2026 |
|
| Engineers Gate Manager | 27k | $47k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 25k | $44k | 100% | Jun 2026 |
|
| Sectoral Asset Management | 22k | $38k | 100% | Jun 2026 |
|
| Raymond James Financial | 21k | $37k | 100% | Jun 2026 |
|
| Sei Investments | 19k | $32k | 100% | Jun 2026 |
|
| Hrt Financial | 17k | $29k | 100% | Jun 2026 |
|
| Point72 Asset Management | 14k | $24k | 100% | Jun 2026 |
|
| Virtu Financial | 14k | $24k | 100% | Jun 2026 |
|
| Royal Bank of Canada | 11k | $20k | 100% | Jun 2026 |
|
| PFS Partners | 11k | $19k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 6.8k | $12k | 100% | Jun 2026 |
|
| Wolverine Asset Management | 3.0k | $5.1k | 100% | Jun 2026 |
|
| Simplex Trading | 399.00 | $689.990700 | 100% | Jun 2026 |
|
| Farther Finance Advisors | 100.00 | $173.000000 | 100% | Jun 2026 |
|
| Aquatic Capital Management | 29.00 | $49.998900 | 100% | Jun 2026 |
|
| SBI Securities | 28.00 | $48.000400 | 0% | Jun 2026 |
|
Who sold out of Engene Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Mar 2026 | 344k | $2.3M |